February 26, 2026: Competitors New GLP-1 Tablet May Have More Side Effects in Head-to-Head Clinical Trial Against Rybelsus Novo Nordisks competitor (Eli Lilly) is developing an oral GLP-1 pill (i.e., orforglipron) that is similar to Rybelsus
The reconstitution calculator eliminates guesswork from this process
"These experimental drugs should never be used by any consumer." Ultimately, there are no circumstances where a GLP-1 drug purchased from an online store without a prescription should be used by a young, active athlete
of this final rule with comment period, we are removing the HCHE measure beginning with the CY 2025 reporting ( period/CY 2027 program determination
DPP-4 inhibitors double the circulating concentrations of both GLP-1 and GIP
Mathis A, Mamidanna P, Cury KM, Abe T, Murthy VN, Mathis MW